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BUT: 
Le but de cette étude était d'évaluer la biocompatibilité à moyen terme d'un 
nouvel implant de zirconium en forme de X dans la chirurgie du glaucome sur 
modèle animal. 
METHODES: 
En préopératoire nous avons mesuré la pression intraoculaire (TIO) et le flux de 
l'humeur aqueuse (FHA) de chaque oeil. Nous avons également effectué des 
images par ultrason de l'angle irido-cornéen (US) de chaque œil. 
Les 2 yeux de chaque sujet étaient opérés d'une sclérectomie profonde mais un 
seul œil recevait l'implant de manière à pouvoir par la suite établir des 
comparaisons. Le choix de l'œil qui recevait l'implant s'est fait de manière 
aléatoire. 
10 lapins ont été suivis en post-opératoire à 1-,2-,3-,4- et 6- mois. 
Après l'intervention la TIO a été contrôlée régulièrement, les US répétés à 1-,3-
et 6- mois post-opératoire et le FHA remesuré à 6-mois post-opératoire. 
A la fin du suivi nous avons analysé les coupes histologiques. 
RESUTATS: 
Pour les 2 groupes (avec implant et sans implant) les valeurs post-opératoires de 
la PIO étaient satisfaisantes. Le FHA dans les 2 groupes s'est initialement 
amélioré pour ensuite redescendre aux même valeurs que celles mesurées en 
préopératoire. La bulle de filtration était plus large à l 'US dans le groupe avec 
implant que dans le groupe sans implant. D'après l'examen microscopique la 
densité des vaisseaux de drainage, les cellules inflammatoires et la fibrose 
étaient plus importantes dans les tissus au pourtour de l'implant. 
CONCLUSIONS : 
Initialement l'implant de zirconium a permis d'augmenter les effets positifs de 
la chirurgie (PIO contrôlée, FHA augmentée). Toutefois après plusieurs mois les 
réactions inflammatoires déclenchées contre le corps étranger et la fibrose ont 
restreint ce bénéfice. Une amélioration de la géométrie de l'implant pourrait 
augmenter les chances de succès. 
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Abstract 
Background The aim of this study was to evaluate the mid-
tenn biocompatibility of a new x-shaped implant made of 
zirconium in an animal mode! of glaucoma surge1y. 
Methods Preoperatively, ultrasound biomicroscopy (UBM), 
intraocular pressure (IOP) and outflow facility (OF) data 
were acquired. Upon surgety, one eye was chosen randomly 
to receive an implant, while the other received none. Ten 
rabbits went through a 1-, 2-, 3-, 4- and 6-month follow-up. 
IOP was measured regularly, UBM performed at 1, 3 and 6 
months after surgery. At the end of the follow-up, OF was 
again measured. Histology sections were analyzed. 
Results For both groups IOP control was satisfactoty, while 
OF initially increased at month 1 to resume preoperative 
values thereafter. Eyes with implants had larger filtration 
blebs which decreased faster than in eyes without the 
implant. Drainage vesse! density, inflammatory cell number 
and fibrosis were higher in tissues near the implant. 
Conclusions The zirconium implant initially promoted the 
positive effects of the surge1y (IOP control, OF increase). 
Nevertheless, after several months, foreign body reactions 
and fibrosis had occurred on some implants that restrained 
the early benefit of such a procedure. Modifications of the 
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zirconium implant geometty could enhance the overall 
success rate. 
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Introduction 
Deep sclerectomy is a non-perforating filtration procedure used 
for the surgical treatment of open-angle glaucoma [1-7]. The 
key idea was to create an efficient filtration through a natural 
membrane without penetrating the anterior chamber. This 
would prevent a sudden drop of resistance, thus avoiding 
postoperative hypotony and other related complications [5, 6]. 
The risk oftriggering a secondmy fibrosis of the filtering 
bleb could lead to subsequent failure to efficiently control 
IOP. In order to maintain an effective aqueous decompres-
sion space, drainage devices can be implanted in the scierai 
space created during surge1y [2-7]. These devices differ in 
material composition, size, shape, consistency, hydration 
ability, and whether or not they can be absorbed [2, 6, 7]. 
Ceramic biomaterials, like alumina and zirconium, have 
been used for decades in orthopaedics [8], dentistty [9, 10] 
and otolaryngology [11]. The biocompatibility of these 
materials makes them a natural choice for designing a 
filtering device which could prevent fibrosis of the filtering 
bleb and would not promote scar formation. We were 
interested in a neutral material onto which inflammatory 
cells would not adhere. The x-shape of the implant was 
chosen based on previous clinicat results from our group 
with devices having the same shape [12]. The aim of this 
study was to evaluate the mid-term biocompatibility of a 
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new x-shaped implant made of zirconium m an animal 
mode! of glaucoma surgery. 
Materials & methods 
Study design 
Deep sclerectomies were performed on both eyes of ten 
New Zealand rabbits. The outflow facility was initially 
measured on each eye. One eye was randomly assigned to 
the implant group ( deep sclerectomy with zirconium 
implant, DSZI), the other one to the control group (deep 
sclerectomy only, DS). Postoperative follow-up periods 
were !, 2, 3, 4 and 6 months, and included two rabbits per 
period. Intraocular pressure was measured three times a 
week for the first 2 weeks, then once a week thereafter. 
Ultrasound biomicroscopy (UBM) examinations were 
performed preoperatively and at !, 3 and 6 months after 
surgety. Rabbits were killed at the end of each follow-up 
period. At the end of the inflation test, before the sacrifice, 
the outflow facility was measured a second time while 
ferritin dye was injected into the anterior chamber. Eyes 
were then enucleated and prepared for histology. 
Mode! used 
Ali experiments were performed on pigmented rabbits 
weighting 2.5 to 3.5 kg. The animais were kept at 21°C 
in a normal 12 hours light/12 hours dark cycle. During ail 
experiments (UBM, surgery, outflow facility measurement), 
general anaesthesia was performed by an intramuscular 
injection of a 37.5 mg/kg Ketamin and a 5.0 mg/kg 
Xylazine solution. At the end of the follow-up, and while 
still under anaesthesia, animais were sacrificed by an 
intravascular injection of 3-5 ml of a 65 mg/ml sodium 
pentobarbital solution. Experiments have been performed in 
compliance with the ARVO statement for the use of 
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animais in ophthalmic research. (http://www.arvo.org/ 
AboutArvo/animalst.asp#Recommended) 
Implants 
The implant was made from medical-grade zirconium 
(courtesy Professor Sami Sandhaus, Lausanne, Switzerland) 
and was designed in a x-shape measuring 4.0x4.0 mm by 
0.8 mm thick (Fig. 1 ). 
Surgical procedure 
Ali deep sclerectomies were performed by the same 
experienced surgeon (SR). Details have been published 
previously [13]. The implant was secured onto the scierai 
bed with a 10/0 nylon suture. After surgety, topical 
application of one drop of 5 mg/g tobramycin and 1 mg/g 
dexamethasone (Tobradex, Alcon, Fort Wotth, TX, USA) 
was given twice a day during the first 3 postoperative days, 
and once a day for the following 7 days. 
Intraocular pressure measurement 
Intraocular pressure measurements were performed with a 
TONO-Pen-XL tonometer (Mentor, Norwell, MA, USA) 
under a drop of local oxybuprocaïn anaesthetic (Novesin, 
Novartis Ophtalmies AG, Switzerland) [14]. The mean of 
three consecutive readings was recorded preoperatively, and 
three times a week postoperatively. To avoid daily and 
individual variation, ail measurements were performed 
between 11 A.M. and 3 P.M. by the same investigator (AB). 
Ultrasound biomicroscopy 
UBM was performed to follow the evolution of the 
operated site [3]. The Humphrey UBM 840 system 
(Humphrey Instrnments, Inc., San Leandro, CA, USA) 
used in B mode provided high-frequency (50 MHz) 
Fig. 1 a Macrophotograph of the zirconium implant. Bar: 4 mm. b Scanning electron microscopy of the implant 6 months after surgery. c 
Magnification from b 
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Fig. 2 Intraocular pressure profile (!OP) before and after deep 
sclerectomy with (DSZI) and without (OS) zirconium implant during 
the 6-month follow-up. The initial postoperative drop was followed by 
a new steady state 
ultrasonic scan images. The UBM pictures were taken at 
the top of the filtration bleb. Al! examinations were 
performed by one single observer (AB) [15]. 
Outflow facility measurement 
To determine the efficacy of deep sclerectomy, outflow 
facility was measured just before surge1y and at the end of 
the follow-up, using an anterior chamber infusion device 
under constant pressure. Details have been reported 
previously. [ 13, 16] 
The pressure was increased by successive 8-mmHg steps 
from baseline IOP up to 32 mmHg. At each pressure level, 
a constant pressure was maintained using an appropriate 
infusion rate. Four pressure levels were recorded. Infusion 
flows were then plotted against pressure and a regression 
line was computed, the slope of the curve representing the 
outflow facility. 
Before killing the animal, a 50 mg/ml cationic ferritin 
dye (horse spleen ferritin, MW=800000, Biochemica, 
Fluka Chemie, Buchs, Switzerland) was injected through 
the catheter into the anterior chamber. While maintaining 
Fig. 3 Ultrasonic biomicro-
scopy preoperatively (a), and at 
1 month post deep sclerectomy 
with (b) a zirconium implant. 
ac: anterior chamber, c: comea, 
cb: ciliary body, i: iris, ib: intra-
scleral filtration bleb, s: sciera, 
tdm: trabeculo-Descemet's 
membrane, zi: zirconium 
implant 
851 
the IOP slightly over 25 mmHg, the ferritin dye was 
allowed to diffuse into the trabecular meshwork and the 
new drainage vessels for about 15 minutes. 
Histology 
The implants were explanted after enucleation, and classi-
cally prepared for scanning electronic microscopy. The eyes 
were prepared for optical microscopy, and sections were 
stained with haematoxylin-eosin (HE) to identify inflam-
matory cells. Haematoxylin-eosin plus Prussian blue 
revealed the ferritin in the drainage vessels, white the 
Goldner trichrome allowed visualization of fibrosis. [ 16] 
Under a 1 Ox magnification, the number of inflammatory 
cells and drainage vessels were counted for each eye in five 
consecutive sections at the surgical site and on native sciera. 
Results were expressed as the difference, and the ratio of 
vessels counted in the operated and native region. The 
scarring response was assessed based on the inflammatory 
cell density and fibrosis thickness in relation to the implant. 
Statistics 
The results were expressed as the mean and standard 
deviation (mean±SD). Parametric comparison between 
means was performed using the unpaired two-tailed 
Student's t-test, and non-parametric comparison was com-
puted with the Mann-Whitney U test. Results were 
considered significant when p<0.05. 
Results 
Intraocular pressure 
The initial post-operative pressure drop was followed by a 
new steady state in both groups (Fig. 2). In the zirconium 
~ Springer 
852 Graefes Arch Clin Exp Ophthalmol 246:849-855 
Table 1 Comparison between the mean intrascleral and subconjonctival bleb thickness (mm) measured on UBM 
Intrascleral bleb Subconjunctival bleb p 
DS DSZI DS DSZI Intrascleral Subconjunctival 
One month 0.36 (±0.10) 0.77 (±0.16) 0.26 (±0.03) 0.51 (±0.14) <0.001 0.45 
Three months 0.26 (±0.09) 0.65 (±0.09) 0.20 (±0.01) 0.39 (±0.05) <0.001 0.42 
Six months 0.27 (±0.18) 0.55 (±0.21) 0.17 (±0.02) 0.38 (±0.18) 0.3 0.28 
Legend: deep sclerectomy with (DSZI) and without (DS) zirconium implant 
implant group, IOP dropped by 25% at 6 months from a 
mean preoperative value of 13.4 mmHg (±2.46). In the 
contrai group, IOP dropped by 32% from a mean 
preoperative value of 13.9 mmHg (±3.35). The IOP drop 
after surge1y was statistically significant in comparison with 
the preoperative values, (p<0.002), but the difference in 
IOP at the end of each follow-up period between both 
groups was not statistically significant (p=0.3). 
Ultrasound biomicroscopy 
The intrascleral and subconjonctival filtration blebs were 
visible on each surgical site for each eye of both groups at 
1, 3 and 6 months postoperatively (Fig. 3). Both intrascleral 
and subconjonctival filtration blebs were thicker in the 
zirconium implant group than in the group without implant 
on eve1y observation, but these differences didn't reach a 
significant level except for the first and third months (Table 1 ). 
Outflow facility 
A slight difference m the mean preoperative outflow 
facility between right 0.34 µ! /mmHg min (±0.11) and 
left 0.43 µ! /mmHg min (±0.13) eyes was noted, but was 
not considered statistically significant (p= NS). Mean 
outflow facility in the contrai group reached maximal values 
during the first (0.6 µl/mmHgmin) and second postoperative 
month (0.5 µl/mmHgmin), and gradually decayed to reach a 
plateau similar to the preoperative value. On the other hand, 
mean outflow facility for the implant group slightly increased 
1 month after surgety, and dropped to lower values than 
preoperative contrai for the rest of the study (p=0.15) (Fig. 4). 
Histology 
In both groups, light microscopy analysis performed 1, 2, 3 
and 4 months after surgery revealed the presence of a 
slightly higher mean number of outflow vessels in the 
sciera at the surgical site (10.6 for the DS group and 15.4 
for the DSZI group respectively) compared to the native 
sciera (2.6). The difference between the surgical and native 
sciera was clearly significant (p<0.001). After 6 months 
there were no longer drainage vessels visible (Table 2). 
~ Springer 
Throughout the entire follow-up, the number of drainage 
channels in the surgical site was higher in the DSZI group 
compared to the DS group, the difference being also 
statistically significant (p<0.001 ). During the en tire follow 
up, a higher number of inflammatory vessels in the surgical 
site compared to the native sciera were visible in both 
groups (Table 3) (p<0.001), and this number was more 
important in the DSZI group than in the DS group. 
The empty space of the extracted implant was lined with 
fibroblasts. The fibroblast reaction was already present 1 
month after surgety, and increased throughout the 6-month 
study (Fig. 5 and Table 3). We have also noticed the 
presence of an inflammatoty reaction, essentially composed 
of giant cells around the suture material, that were barely 
visible at 1 month, but which were more pronounced at 6 
months (Fig. 5). 
Discussion 
Our study aims to assess the biocompatibility and efficiency 
of a zirconium implant in deep sclerectomy using an animal 
mode!. This implant being non-resorbable, it should be 
adequate to preserve an intrascleral space and to maintain 
good filtration, and the x-shape should increase the volume 
of the filtration bleb. 
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Fig. 4 Comparison of preoperative and postoperative mean outflow 
facility (OF) in DSZI and DS during the 6-month follow-up 
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Table 2 Comparison between the mean numbers of drainage vessels observed with light microscopy. Thickness of the fibrosis around the 
implant. Deep sclerectomy with (DSZI) and without (DS) zirconium implant 
Snrgical site Non snrgical site New channels Fibrosis (µm) 
DS DSZl DS DSZl DS DSZl DSZI 
l month 0.30 (±0.42) 2.70 (±3.81) p<0.001 0.25 (±0.07) 0.30 (±0.42) t 0.05 2.4 13 l.25 (±8.8) 
2 months 0.25 (±0.35) 0.80 (±0.28) p<0.001 0.10 (±0.14) 0.00 (±0.00) t 0.15 0.80 118.75 (±8.8) 
3 months 0.00 (±0.00) 0.30 (±0.42) t 0.00 (±0.00) 0.25 (±0.35) t 0.05 0.15 75 (±0.00) 
4 months l.25 (±0.35) 1.80 (±1.69) p<0.01 0.50 (±0.48) 0.00 (±0.00) t 0.75 1.80 137.5 (±17.68) 
6 months 0.00 (±0.00) 0.00 (±0.00) 0.00 (±0.00) 0.00 (±0.00) 0.00 0.00 162.5 (±53.03) 
f=NS 
Our study showed a postoperative IOP-lowering effect in 
both DS and DSZI groups achieved soon after surgery, 
followed by a slight increase 3 months after surgery. This 
tendency was not incredibly surprising because, firstly, the 
animais used were non-glaucomatous, and secondly, an 
adaptation to the surgically modified outflow facility was 
conceivable. Similarly, an increased aqueous production 
would counter the increased outflow facility. 
White the thickness of both subconjonctival and intra-
scleral filtration blebs was larger in the DSZI group than the 
DS-only group, we still obse1ved a faster subconjonctival 
and intrascleral bleb thickness reduction in the DSZI group 
than in the DS group, which could be explained by a 
inflammatory reaction that induced fibrosis. 
After performing a deep sclerectomy, removing the main 
obstacle to aqueous humour outflow, we would have 
anticipated a marked and sustained increase in the outflow 
facility over time. This increase was noticed for both 
groups during the first month only. For the following 5 
months, the outflow facility progressively decreased to 
reach preoperative values. This reduction in outflow facility 
could be explained by the occurrence of tissue remodelling 
at the surgical site or around the filtering bleb, induced or 
promoted by the surge1y and or the implant. This reaction 
was apparently more important in the DSZI group. 
Light microscopy showed the development of new 
intrascleral drainage ducts around the surgical site, which 
were slightly more important in the zirconium implant 
group, thus supporting the hypothesis that the implant was 
enhancing development and growth of new vessels in the 
surgical bed. Histological detection of drainage vessels was 
limited to the ferritin measurement. Ethier and Chan 
demonstrated in a study on human eyes that cationic 
ferritin reduces the outflow facility, presumably by binding 
to negatively charged sites in the outflow pathway, at the 
inner wall of Schlemm's canal [17]. To avoid methodolog-
ical bias in measuring outflow facility affected by such a 
drawback, we have infused only for a brief period ( 15 
minutes) in the anterior chamber, which should explain low 
ferritin coloration on the sections. 
The drainage space was lined with spindle cells at the 
implant location and surrounded by fibrosis. In the deep 
sclerectomy-only sections, an irregular canal without spindle 
cells was observed. Contraiy to the other non-absorbable 
implants (HEMA, PMMA) which are soft, the zirconium 
implant is ve1y hard. This results in a huge difference in 
compliance when compared to the more flexible eye tissues. 
This strong difference between the implant and the sciera 
could be responsible for micro movements of the implant 
during the microscopie sciera expansion, and contraction 
during the circadian IOP changes. These movements were 
sufficient to induce a significant shear at the interface, 
resulting in a chronic inflammatory response and leading to 
important scarring around the zirconium implant in the later 
phases. The quality of the implant surface could also have 
played a particular role in this complication. Imperfectly 
Table 3 Comparison between the mean numbers of i11f/a111111at01y channels observed with light microscopy. Deep sclerectomy with (DSZI) and 
without (DS) zirconium implant 
Snrgical site Non surgical site New channels 
DS DSZI DS DSZI DS DSZl 
l month 6.05 (±1.48) 12.90 (±2.69) p<0.001 l .55 (±0.49) 2.35 (±0.21) p<0.05 4.50 10.55 
2 months 7.15 (±0.49) 15.10 (±2.12)p<0.00l 3.25 (±1.06) 2.30 (±0.14) p<0.05 3.95 12.80 
3 months 5.77 (±0.80) 13.70 (±0.71) p<0.001 2.60 (±0.85) 2.85 (±0.21) t 3.17 10.85 
4 months 7.20 (±2.63) 10.40 (±3.68) p<0.01 1.95 (±0.78) 1.00 (±0.28) t 5.25 9.40 
6 months 10.60 (±2.26) 15.37 (±2.30)p<O.OOI 2.70 (±0.42) 2.35 (±1.20) t 7.9 13 
t=NS 
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Fig. 5 Histological examination of the surgical site 6 months after DSZI 
showing ferritin dye (b/11e) in the trabeculum and drainage vessels 
(H&E). !11sert: giant cells (red arrow), suture material (black arrow) 
polished surfaces, sharp edges or too thick an implant could 
have worsened the inflammatoty response (Fig. 1 b ). The 
effect of the implant on the surgical site seemed to be 
influenced not only by the material used, which is known to 
have a good intrinsic biocompatibility, but also by other 
geometrical features causing interferences in this study. The 
data based on histology supports the hypothesis that the 
zirconium implant in our mode! promotes scar formation 
rather than preventing such reaction. In the context of the 
filtering surge1y, such implant failed to prevent formation of 
fibrosis, a reported complication of the glaucoma surgery. 
The surface of the implant was not massively invaded by 
inflammatory cells (Fig. 1 b ), which validated the initial 
hypothesis that the material would not be prone to cell 
adhesion. Adverse events affecting the surrounding tissues 
could have triggered a foreign-body reaction in the presence 
of the implant, thus promoting the fibrosis around the device 
instead of limiting the extent of the scarring response. 
The general conclusions of this study were limited by a 
few factors. These rabbits were not suffering from 
glaucoma, and the anatomy of their eyes was normal in 
ail respects. The number of experiments conducted was 
somewhat too small to draw a definitive conclusion on 
glaucoma surgety with ceramic implants. Further studies 
should be performed to determine the real biocompatibility 
of this implant in glaucoma surgety. 
In conclusion, this study repotted results of experimental 
non-penetrating glaucoma surge1y with zirconium implants 
on rabbit eyes. Initial IOP drop after surgety was followed 
by a slow return to preoperative values. UBM images show 
intrascleral and subconjunctival filtering blebs to be larger 
in the zirconium group. Bleb height was progressively 
reduced until the 6th month. Outflow facility was signifi-
cantly increased in eyes having only non-penetrating 
~ Springer 
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surgery without implant for the first 2 months, and returned 
to normal thereafter. Zirconium-implanted eyes have not 
shown any significant increase in outflow facility after 
surge1y. From histology, we observed that the number of 
drainage vessels were slightly higher for the zirconium 
group compared to the group without the implant. Fibrosis, 
scar formation and inflammat01y response were significant-
ly more pronounced in the zirconium group. These 
reactions were probably the main reason for the relative 
failure in this implant surgery despite well-known biocom-
patibility of this material in bioprosthesis. As it stands, this 
implant failed to prevent the scarring response of the 
filtering bleb in an experimental mode! of glaucoma 
surgery. Modifications of the zirconium implant geometty 
could enhance the overall success rate. 
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